WO2003016561A3 - Verfahren zur herstellung von cna - Google Patents
Verfahren zur herstellung von cna Download PDFInfo
- Publication number
- WO2003016561A3 WO2003016561A3 PCT/EP2002/009044 EP0209044W WO03016561A3 WO 2003016561 A3 WO2003016561 A3 WO 2003016561A3 EP 0209044 W EP0209044 W EP 0209044W WO 03016561 A3 WO03016561 A3 WO 03016561A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cna
- production
- relates
- producing
- novel method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003521868A JP2005500391A (ja) | 2001-08-13 | 2002-08-13 | Cnaの製造方法 |
EP02794784A EP1427710A2 (de) | 2001-08-13 | 2002-08-13 | Verfahren zur herstellung von cna |
US10/486,597 US20040249152A1 (en) | 2001-08-13 | 2002-08-13 | Method for the production of cna |
AU2002333408A AU2002333408A1 (en) | 2001-08-13 | 2002-08-13 | Method for the production of cna |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10139730A DE10139730A1 (de) | 2001-08-13 | 2001-08-13 | Verfahren zur Herstellung CNA |
DE10139730.5 | 2001-08-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003016561A2 WO2003016561A2 (de) | 2003-02-27 |
WO2003016561A3 true WO2003016561A3 (de) | 2003-12-04 |
Family
ID=7695308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/009044 WO2003016561A2 (de) | 2001-08-13 | 2002-08-13 | Verfahren zur herstellung von cna |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040249152A1 (de) |
EP (1) | EP1427710A2 (de) |
JP (1) | JP2005500391A (de) |
AU (1) | AU2002333408A1 (de) |
DE (1) | DE10139730A1 (de) |
WO (1) | WO2003016561A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6920411B2 (ja) * | 2016-07-25 | 2021-08-18 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | コリンキナーゼ阻害剤としてのプリン及び3−デアザプリンアナログ |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015509A2 (de) * | 1997-09-22 | 1999-04-01 | Aventis Research & Technologies Gmbh & Co. Kg | Cyclohexyl- und heterocyclyl-nukleosid derivate, die herstellung und verwendung dieser derivate, deren oligomere bzw. konjugate in paarungs- und/oder testsystemen |
-
2001
- 2001-08-13 DE DE10139730A patent/DE10139730A1/de not_active Withdrawn
-
2002
- 2002-08-13 US US10/486,597 patent/US20040249152A1/en not_active Abandoned
- 2002-08-13 WO PCT/EP2002/009044 patent/WO2003016561A2/de not_active Application Discontinuation
- 2002-08-13 JP JP2003521868A patent/JP2005500391A/ja not_active Ceased
- 2002-08-13 EP EP02794784A patent/EP1427710A2/de not_active Withdrawn
- 2002-08-13 AU AU2002333408A patent/AU2002333408A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015509A2 (de) * | 1997-09-22 | 1999-04-01 | Aventis Research & Technologies Gmbh & Co. Kg | Cyclohexyl- und heterocyclyl-nukleosid derivate, die herstellung und verwendung dieser derivate, deren oligomere bzw. konjugate in paarungs- und/oder testsystemen |
Non-Patent Citations (1)
Title |
---|
KARIG, G. ET AL.: "DELTA-PEPTIDE ANALOGUES OF PYRANOSYL-RNA", HELV. CHIM. ACTA, vol. 83, 2000, pages 1049 - 1078, XP002221365 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002333408A1 (en) | 2003-03-03 |
EP1427710A2 (de) | 2004-06-16 |
JP2005500391A (ja) | 2005-01-06 |
DE10139730A1 (de) | 2003-02-27 |
WO2003016561A2 (de) | 2003-02-27 |
US20040249152A1 (en) | 2004-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003284443A1 (en) | Tire molding system, tire production system having the same, and tire producing method | |
AU2002250858A1 (en) | Capsule-in-capsule system and method for the production thereof | |
AU2002321292A1 (en) | Hybrid membrane, method for the production thereof and use of said membrane | |
MXPA03010322A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE POLIISOCIANATOS. | |
HUP0303590A3 (en) | Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines | |
AU2002358514A1 (en) | Nanocapsules and microcapsules comprising reactive polymers and method for the production thereof | |
AU2002301989A1 (en) | Episulfide compound, method for producing the same and optical product comprising the same | |
AU2001254607A1 (en) | Semiconductor polymers, method for the production thereof and an optoelectronic component | |
WO2003016561A3 (de) | Verfahren zur herstellung von cna | |
AUPR270701A0 (en) | Composite and metal component production, forming and bonding system | |
WO2002096799A3 (de) | Siliciumsubnitrid, ein verfahren zur dessen hestellung und die verwendung des subnitrids | |
AU2002358738A1 (en) | Method for the production of polymers | |
AU2002348998A1 (en) | N-methyl-homocystines, use thereof and method for the production thereof | |
AU2002358739A1 (en) | Method for the production of polymers | |
AU6907201A (en) | Method for the production of caprolactam | |
AU2002241418A1 (en) | Novel photorefractive materials, intermediate products for producing said materials and method for the production thereof | |
AU2002212266A1 (en) | Branched polymers, method for the production thereof, and their use | |
AU2001278703A1 (en) | Process for the production of block copolymers, block copolymers produced by the process, and use of the copolymers | |
AU2002329252A1 (en) | Polysubstituted indan-1-ol systems, method for the production and use thereof as drugs | |
AU2002336982A1 (en) | C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments | |
AU2002357482A1 (en) | Method for the production of desclarithromycin, and intermediate products | |
AU4692501A (en) | Laminaribiose phosphorylase, process for producing the same and process for producing laminarioligosaccharide by using the enzyme | |
AU2002333003A1 (en) | Complexating systems, intermediates for their production and method for obtaining and using the same | |
AU2003222771A1 (en) | Ceramic mixture, relative method and production system and ceramic products obtained from said mixture | |
IL161800A0 (en) | Method for the production of desclarithromycin, and intermediateproducts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002794784 Country of ref document: EP Ref document number: 2003521868 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002794784 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10486597 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002794784 Country of ref document: EP |